Use access key #2 to skip to page content.
$5.75 0.19 (3.42%)
11/21/2008 4:00 PM

Acura Pharmaceuticals Inc. (ACUR)

CAPS Rating:
*

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ACUR

Add Stock to Watchlist

What the Community Thinks

Total Members

19 Outperforms
32 Underperforms
 

All-Stars

1 Outperforms
19 Underperforms
 

Members bullish on ACUR are also bullish on:

Members bearish on ACUR are also bearish on:

Ticker Tags

Pharmaceuticals (148), Micro Cap (5043)
Suggest a tag

Acura Pharmaceuticals Inc. At A Glance

Current Price: $5.75
Last Trade Time: 11/21/2008 4:00 PM
Open: $5.60
Previous Close: $5.56
Daily Range: $5.25 - $5.75
52-Week Range: $3.43 - $10.50
Volume: 29,235
Market Cap: $237.54M
P/E Ratio: 8.69
Compare Our Special Broker Offers!

Stock Trends

ACUR VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ACUR

More Headlines...

Top Bull Pitch

Recs

1

Acura Pharmaceuticals Inc. (ACUR)

Avatar davidr825 (24.10) Submitted: 6/13/08 7:58 PM

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Acura Pharmaceuticals Inc. (ACUR)

Avatar tcampbellla (92.13) Submitted: 10/29/07 3:16 PM

No thanks.

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 7 :   1 2 Next »

Show Pitch Replies

Recs

0

 (ACUR)

Avatar OtherOracleOfOMA (66.52) Submitted: 10/24/08 4:11 AM : Underperform Start Price: $6.11 ACUR Score: -4.03

This company is founded on nothing but naivety and wishful thinking. The sincerity of the drug companies when they say they want to reduce abuse of prescription drugs is about as believable as the beer companies' professed desire to forgo a third or more of their revenues by eliminating underage drinking. Eventually, ACUR will be revealed as a fraud of a company, whose incompetent management pissed away millions of dollars developing an utterly useless product which consists of an abuse deterrent filler that any junkie can neutralize in a second.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ACUR)

Avatar manvsmonkey (44.17) Submitted: 7/28/08 2:09 PM : Outperform Start Price: $7.30 ACUR Score: 17.72

seems like the phase III trial is going well

http://seekingalpha.com/article/87373-a-biotech-bloom-in-july?source=side_bar_long_ideas

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ACUR)

Avatar rvood (37.98) Submitted: 7/23/08 12:25 AM : Outperform Start Price: $7.67 ACUR Score: 15.73

New Aversion technology, phase 3 appears to be going well, licensing agreements in place, R&D being paid for by King, low float, pipeline ever increasing, starting to get looked at by funds, etc, too many druggies out there, what's not to like.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ACUR)

Avatar davidr825 (24.10) Submitted: 6/13/08 7:58 PM : Outperform Start Price: $9.54 ACUR Score: 4.63

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ACUR)

Avatar tcampbellla (92.13) Submitted: 10/29/07 3:16 PM : Underperform Start Price: $19.30 ACUR Score: 19.40

No thanks.

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 7 :   1 2 Next »

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links